{"id":"https://openalex.org/W4386793483","doi":null,"title":"Updated key points of the 2019 EASL guidelines for drug-induced liver injury and its practice in China","display_name":"Updated key points of the 2019 EASL guidelines for drug-induced liver injury and its practice in China","publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W4386793483"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:74c2daaee85446928594e1805eba5359","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/74c2daaee85446928594e1805eba5359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang Gandanbing Zazhi, Vol 36, Iss 3, Pp 505-508 (2020)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/74c2daaee85446928594e1805eba5359","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"YU Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166055","display_name":"Shenzhen Third People\u2019s Hospital","ror":"https://ror.org/04xfsbk97","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166055"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"YU Hong","raw_affiliation_strings":["Shenzhen Third People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shenzhen Third People\u2019s Hospital","institution_ids":["https://openalex.org/I4210166055"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210166055"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":1.0},{"id":"https://openalex.org/keywords/easl-guidelines","display_name":"EASL guidelines","score":0.7300000190734863},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7110000252723694},{"id":"https://openalex.org/keywords/antituberculosis-drugs","display_name":"antitubercular agents","score":0.8740000128746033},{"id":"https://openalex.org/keywords/causality-assessment","display_name":"causality assessment","score":0.8410000205039978},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.6847342252731323},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.6249721646308899},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5200240612030029},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.5047115087509155},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.48418763279914856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4392622113227844},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2899462580680847},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2186305820941925},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.18716692924499512},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.17040807008743286},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.13165226578712463},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.05971214175224304}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:74c2daaee85446928594e1805eba5359","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/74c2daaee85446928594e1805eba5359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang Gandanbing Zazhi, Vol 36, Iss 3, Pp 505-508 (2020)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:74c2daaee85446928594e1805eba5359","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/74c2daaee85446928594e1805eba5359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang Gandanbing Zazhi, Vol 36, Iss 3, Pp 505-508 (2020)","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392146720","https://openalex.org/W3006897612","https://openalex.org/W4320004728","https://openalex.org/W2993569301","https://openalex.org/W3190660611","https://openalex.org/W3192426205","https://openalex.org/W2606888484","https://openalex.org/W2165788910","https://openalex.org/W4288340389","https://openalex.org/W7169785460"],"abstract_inverted_index":{"To":[0],"further":[1],"understand":[2],"the":[3,15,20,29,34,69,91,95,99,120,152],"2019":[4],"EASL":[5,96],"Guidelines":[6],"for":[7,68,76,84,110,119,151],"drug-induced":[8],"liver":[9],"injury":[10],"(DILI),":[11],"this":[12],"article":[13],"outlined":[14],"updated":[16],"key":[17],"points":[18,25],"of":[19,31,36,57,60,71,94,101,122,130,156],"guidelines":[21,97,145],"and":[22,42,50,81,103,117,125,140,154],"analyzed":[23],"these":[24,144],"with":[26,132],"reference":[27,149],"to":[28],"reality":[30],"China,":[32],"including":[33],"type":[35],"DILI,":[37,58,105,131],"DILI":[38,61,77,111,136,157],"induced":[39,62,112,137],"by":[40,63,113,138],"herbs":[41,139],"dietary":[43,141],"supplements,":[44],"prospective":[45],"versus":[46],"retrospective":[47],"studies,":[48],"diagnosis":[49,100,153],"causality":[51],"assessment,":[52],"risk":[53],"factors,":[54],"special":[55,128],"phenotypes":[56,129],"management":[59,108],"immune":[64,114],"checkpoint":[65,115],"inhibitors,":[66],"indication":[67],"withdrawal":[70,121],"antitubercular":[72,123],"agents,":[73,124],"new":[74,92],"biomarkers":[75],"under":[78],"clinical":[79],"research,":[80],"therapeutic":[82],"drugs":[83],"DILI.":[85],"It":[86],"is":[87],"pointed":[88],"out":[89],"that":[90],"version":[93],"redefined":[98],"acute":[102],"chronic":[104],"provided":[106],"detailed":[107],"strategies":[109],"inhibitors":[116],"criteria":[118],"summarized":[126],"several":[127],"an":[133],"emphasis":[134],"on":[135],"supplements.":[142],"Therefore,":[143],"have":[146],"a":[147],"good":[148],"value":[150],"treatment":[155],"in":[158],"China.":[159]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-09-16T00:00:00"}